Promoting filamin A cleavage in androgen-dependent prostate cancer may therefore hold therapeutic advantage in preventing tumour metastasis, by increasing cleaved filamin A product nuclear translocation and inhibition of AR. This evidence concerns the gene AR and neoplasm.